Selected article for: "clinical development and HCV therapy"
Author: De Clercq, Erik
Title: Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses
  • Cord-id: 7ujqdujd
  • Document date: 2007_9_2
    • ID: 7ujqdujd
    Snippet: More than 40 compounds have been formally licensed for clinical use as antiviral drugs, and half of these are used for the treatment of HIV infections. The others have been approved for the therapy of herpesvirus (HSV, VZV, CMV), hepadnavirus (HBV), hepacivirus (HCV) and myxovirus (influenza, RSV) infections. New compounds are in clinical development or under preclinical evaluation, and, again, half of these are targeting HIV infections. Yet, quite a number of important viral pathogens (i.e. HPV
    Document: More than 40 compounds have been formally licensed for clinical use as antiviral drugs, and half of these are used for the treatment of HIV infections. The others have been approved for the therapy of herpesvirus (HSV, VZV, CMV), hepadnavirus (HBV), hepacivirus (HCV) and myxovirus (influenza, RSV) infections. New compounds are in clinical development or under preclinical evaluation, and, again, half of these are targeting HIV infections. Yet, quite a number of important viral pathogens (i.e. HPV, HCV, hemorrhagic fever viruses) remain in need of effective and/or improved antiviral therapies.

    Search related documents:
    Co phrase search for related documents
    • acid derivative and action mechanism: 1, 2, 3, 4, 5
    • acid derivative and action novel mechanism: 1
    • acid derivative and active site: 1, 2
    • acid derivative and low molecular weight: 1
    • action mechanism and acyclovir resistant: 1